Status:
NOT_YET_RECRUITING
Insights Into Participating in Studies for Uterine Cancer
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Uterine Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this trial so that it may collect a variety of data about u...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Diagnosis of uterine cancer
- No prior treatment for uterine cancer
Exclusion
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05998811
Start Date
September 1 2024
End Date
September 1 2026
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107